Hong Kong
Search
Sign In
Change Password
Points
Sign Out
Podcast: Dr Dennis Slamon says MONALEESA-3 supports the potential of CDK4/6 inhibitors in the first-line setting for HR+/HER2- breast cancer
11 Oct 2019
Podcast: Dr Dennis Slamon says MONALEESA-3 supports the potential of CDK4/6 inhibitors in the first-line setting for HR+/HER2- breast cancer
Wait Loading...